Intelligence Driven Advisers, LLC Johnson & Johnson Transaction History

Intelligence Driven Advisers, LLC

$706 Million
Q2 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$168.19 - $186.01 $165,330 - $182,847	-983 Reduced 42.3%	1,341 $239,000
Q1 2022 Apr 25, 2022	SELL	$158.14 - $179.59 $16,288 - $18,497	-103 Reduced 4.24%	2,324 $422,000
Q4 2021 Feb 02, 2022	SELL	$155.93 - $173.01 $955,071 - $1.06 Million	-6,125 Reduced 71.62%	2,427 $407,000
Q4 2021 Jan 19, 2022	BUY	$155.93 - $173.01 $955,850 - $1.06 Million	6,130 Added 253.1%	8,552 $1.47 Million
Q3 2021 Oct 14, 2021	BUY	$161.5 - $179.47 $7,590 - $8,435	47 Added 1.98%	2,422 $387,000
Q2 2021 Jul 29, 2021	BUY	$159.48 - $171.07 $378,765 - $406,291	2,375 New	2,375 $391,000
Q1 2021 Apr 13, 2021	SELL	$153.07 - $170.48 $512,172 - $570,426	-3,346 Closed	0 $0
Q4 2020 Jan 19, 2021	BUY	$137.11 - $157.38 $367,043 - $421,306	2,677 Added 400.15%	3,346 $527,000
Q4 2020 Jan 13, 2021	SELL	$137.11 - $157.38 $377,875 - $433,739	-2,756 Reduced 80.47%	669 $527,000
Q3 2020 Oct 09, 2020	SELL	$140.38 - $153.83 $11,651 - $12,767	-83 Reduced 2.37%	3,425 $510,000
Q2 2020 Aug 14, 2020	SELL	$128.81 - $155.51 $7,857 - $9,486	-61 Reduced 1.71%	3,508 $493,000
Q1 2020 Sep 04, 2020	SELL	$111.14 - $153.99 $88,245 - $122,268	-794 Reduced 18.2%	3,569 $468,000
Q4 2019 Sep 04, 2020	SELL	$127.5 - $146.44 $16,447 - $18,890	-129 Reduced 2.87%	4,363 $636,000
Q3 2019 Sep 04, 2020	BUY	$126.95 - $142.14 $41,893 - $46,906	330 Added 7.93%	4,492 $581,000
Q2 2019 Sep 04, 2020	BUY	$131.15 - $144.24 $67,411 - $74,139	514 Added 14.09%	4,162 $580,000
Q1 2019 Sep 04, 2020	BUY	$125.72 - $139.79 $22,378 - $24,882	178 Added 5.13%	3,648 $510,000
Q4 2018 Sep 04, 2020	BUY	$122.84 - $147.84 $426,254 - $513,004	3,470 New	3,470 $448,000

Others Institutions Holding JNJ

# of Institutions

4,161

Shares Held

1.69B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $431B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Intelligence Driven Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intelligence Driven Advisers, LLC with notifications on news.

Account